A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas

por Eroglu, Z, Tawbi, H A, Hu, J, Guan, M, Frankel, P H, Ruel, N H, Wilczynski, S, Christensen, S, Gandara, D R, Chow, W A
Publicado 2015